Hepatitis C: A projection of the healthcare and economic burden in the UK


2013 by RAND - Bhanu Patruni and Ellen Nolte
Hepatitis C is a leading cause of chronic liver disease, end-stage cirrhosis and liver cancer, with the UK lagging behind a number of European countries in disease detection and treatment. This study sought to contribute to better understanding of the burden associated with HCV infection in the UK through estimating prevalence and number of deaths attributable to HCV infection, and by assessing the associated healthcare and societal costs. Using a cohort simulation model, the study projects the burden of infection, increased healthcare costs and loss of economic productivity according to various HCV diagnosis and treatment scenarios. It suggests that treatment rates must quadruple to halt the rise in projected prevalence.